Since the holidays, there's been an uptick in cases of flu and other viruses in the region, health officials say.

A recent study from the University of California, San Francisco, offers a closer look at how some patients respond to extended courses of Paxlovid, a combination of nirmatrelvir and ritonavir.

Some long COVID patients who took an extended course of Paxlovid saw temporary or lasting improvement, according to a small new case series published in the journal Communications Medicine. A previous ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

Can Paxlovid treat long COVID? A new report suggests it might help some patients, but which patients might benefit remains unclear. The report, published last week in the journal Communications ...

Among high-risk patients, treatment with paxlovid reduces the COVID-19 burden. Researchers conducted a phase 2/3, double-blind, randomized study (Evaluation of Protease Inhibition for COVID-19 in ...

However, it can be tricky to know if you are buying from a legitimate business. Before you buy from an online pharmacy, you'll want to find out whether it's properly licensed. Organizations such as ...

He followed medical guidance and stopped taking his cholesterol medication until he completed his course of Paxlovid. His problem came at the next step when a pharmacy worker convinced him that he ...

It’s January, which means your Instagram feed, your favorite podcast, and every storefront you pass is brimming with ideas for New Year’s goals and intentions. You’re all for hitting the ...

Cuban’s approach seems to be impacting pharmacy giants like CVS and Walgreens, who are now following Cost Plus’ blueprint to offer transparent drug pricing. As 2025 unfolds, the pharmaceutical ...

CVS Health stock has badly underperformed the ... with health insurance, pharmacy benefits management, and pharmacy retail all under one umbrella. There were rumors last year that the company ...

The findings run counter to a clinical trial which found no benefit from Paxlovid in long COVID patients WEDNESDAY, Jan. 8, 2024 (HealthDay News) -- The antiviral pill Paxlovid might help some ...